Addressing COVID-19 impact. Ensuring progress.

From site access to patient recruitment to drug delivery, the impact of COVID-19 on clinical development is widespread.  IQVIA is helping to ensure our customers can continue to study disease, help patients and continue innovation -- during this crisis and beyond.
Contact US

A new reality for clinical trials

In a few short months, COVID-19 has transformed how healthcare works. It has diverted expertise and resources and changed the way patients are diagnosed and treated. Disrupted the development and delivery of medicines.

The result is a new environment for clinical trials. And while some issues may resolve in the short term, others may signal a more permanent shift.

That is why IQVIA deployed a task force dedicated to ensuring patient safety and trial continuity. We are here to help customers navigate today’s challenges and ensure your business, and your commitment to patients, remains strong.

Iqiva Covid-19 clinical trial

Standardized risk assessments. Custom solutions.

IQVIA’s Research & Development Solutions COVID-19 task force quickly mobilized to develop a standardized approach to risk assessment for both in-flight and new trials.

Customers receive custom reports detailing risks and mitigation strategies to support trial continuity and patient safety, and to help you continue to drive healthcare forward - today.

IQVIA Global Regulatory Affairs: Committed to helping you address the impact of COVID-19 today, and provide hope for the future
IQVIA Global Regulatory Affairs: Committed to helping you address the impact of COVID-19 today, and provide hope for the future

Strategic regulatory support 

In-flight studies may require protocol modifications to ensure patient visits and dosing continue; IQVIA’s regulatory experts offer guidance to support this flexibility in trial delivery.

Whether amendments for home visits, support for IRB submissions, or approvals for protocol modifications or other global regulatory documents, our experts can help.

Learn more

Supported patients. Trial continuity.

Telemedicine empowered.
Travel restrictions and limitations on face-to-face interactions may necessitate moving to a fully remote or hybrid decentralized trial model to help ensure continuity and compliance. IQVIA Study Hub is a cloud platform that allows patients and study teams to securely connect in a televisit. It also gives patients the ability to upload medical history or patient reported outcomes easily from their tablet, smartphone or web browser.

Patients need to stay home. Meet them there.
Some trial patients may require home-based care. Through our network of partners, IQVIA offers at-home support by trained nurses and phlebotomists, helping to reduce the risk of infection in healthcare settings.

We further support in-home visits by shipping lab supplies and investigational product to the patient or the home health nursing partner.

COVID-19 Clinical Trial Solutions
Virtual Trials

Bring trials directly to patients to decrease costs, increase quality and improve access.

Clinical Monitoring

Enhance patient safety and study quality by using data, analytics, and technology to monitor patient, site, and study performance with risk-based and centralized monitoring.

Regulatory Affairs

Navigate complex regulatory requirements with expert insights and bring transparency, efficiency and predictability to your regulatory affairs strategy.

Centralized monitoring Covid-19
Centralized monitoring Covid-19

Centralized monitoring for safety and continuity

Whether through televisits, site visits or home-based care, IQVIA  is effectively monitoring sites and patients through remote monitoring. By leveraging centralized monitoring, we are pivoting clinical trials from traditional monitoring to proven risk-based monitoring solutions, allowing a rapid mitigation strategy for COVID-19 impact. This approach includes

  • Study risk assessments to identify the optimum remote monitoring strategy to support patient safety and data quality
  • Our global scale to rapidly deploy risk-based analytics and remote mitigation steps

1,000 virtual meetings

Investigator meetings conducted since 2018
Business woman using laptop
Business woman using laptop

Maintain timelines

As more interactions are moving to virtual settings, it is critical to ensure timelines and productivity are maintained.

IQVIA’s experienced facilitators are a seamless extension of your study team, providing content creation and delivery as well as logistics and technical management.

Supported by professional trainers, behavioral strategists, medical writers and technical producers, our team has facilitated more than 1,000 virtual meetings in the past two years earning a >90% satisfaction rating.

Managing biological samples for continuity

IQVIA works closely with Q2 Solutions, a joint venture between IQVIA and Quest Diagnostics.

Q2 Solutions is fully operational and is working with multiple customers to expedite study launch for potential COVID-19 vaccines and treatments. We have also partnered with the University of Texas Medical Branch to develop an assay to help determine the effectiveness of vaccine candidates in protecting a person from COVID-19, and are collaborating with government and private healthcare companies in using our resources to support community testing efforts.

Infectious Diseases and Vaccines

Leverage numerous infectious disease and vaccine experts using best-in-class data sources and the right sites.

COVID-19 Healthcare Insights and Resources

We are committed to reducing the impact of COVID-19. Learn more about how we are helping.

Clinical Trials

Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.

Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.